Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sogo, S.
Right arrow Articles by Ikehara, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sogo, S.
Right arrow Articles by Ikehara, S.
Stem Cells, Vol. 15, No. 6, 420-429, November 1997
© 1997 AlphaMed Press

Induction of c-kit Molecules on Human CD34+/c-kit<low Cells: Evidence for CD34+/c-kit<low Cells as Primitive Hematopoietic Stem Cells

Shinji Sogoa,b, Muneo Inabab, Hajime Ogatac, Hiroko Hishab, Yasushi Adachib, Shin-ichiro Morib, Junko Tokib, Kazuya Yamanishia, Hideharu Kanzakid, Masakazu Adachia, Susumu Ikeharab

a Cellular Technology Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan;
b First Department of Pathology,
c Department of Pediatrics,
d Department of Obstetrics and Gynecology, Kansai Medical University, Moriguchi City, Osaka, Japan

Key Words. c-kit • CD34 • Human cord blood • Hematopoietic stem cells

Dr. Susumu Ikehara, First Department of Pathology, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570, Japan.

c-kit, a receptor for stem cell factor, has been widely accepted as a distinctive marker for hematopoietic stem cells. However, the level of c-kit expression on pluripotent hematopoietic stem cells is still controversial in mice and humans. We purified CD34+/c-kit<low cells (phenotypically c-kit-negative but only detectable at the message level) from human cord blood and examined their maturational steps in relation to the expression of c-kit molecules. When the CD34+/c-kit<low cells were cultured with cytokines (flt 3 ligand, interleukin 6 and interleukin 7) plus immobilized anti-CD34 monoclonal antibody (to crosslink CD34 molecules), c-kit molecules were clearly induced within 24 h. The c-kit expression gradually increased until day 8. When CD34+/c-kitlow or CD34+/c-kit+ cells that had been induced from CD34+/c-kit<low cells were resorted and recultured using a methylcellulose culture system, they showed the same colony-forming ability as the freshly isolated CD34+/c-kitlow or CD34+/c-kit+ cells, respectively. Furthermore, CD34+/c-kit<low cells have a similar hematopoietic potential to CD34+/c-kitlow cells in assays for long-term culture initiating cell and colony-forming unit culture generated from long-term cultures. These findings suggest that CD34+/c-kit<low cells mature into CD34+/c-kitlow and CD34+/c-kit+ cells, and acquire the reactivity to various humoral hematopoietic stimuli. Moreover, CD34+/c-kit<low cells showed a low level of rhodamine 123 retention, suggesting that CD34+/c-kit<low cells have multidrug resistance. Therefore, the CD34+/c-kit<low cells without colony-forming unit-granulocyte-erythroid-macrophage-megakaryocyte activity are also a pluripotent hematopoietic stem cell population, and the expression of c-kit on c-kit<low cells is the first maturational step of hematopoiesis.




This article has been cited by other articles:


Home page
Stem CellsHome page
T. Kimura, R. Asada, J. Wang, T. Kimura, M. Morioka, K. Matsui, K. Kobayashi, K. Henmi, S. Imai, M. Kita, et al.
Identification of Long-Term Repopulating Potential of Human Cord Blood-Derived CD34-flt3- Severe Combined Immunodeficiency-Repopulating Cells by Intra-Bone Marrow Injection
Stem Cells, June 1, 2007; 25(6): 1348 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Matsumura-Takeda, S. Sogo, Y. Isakari, Y. Harada, K. Nishioka, T. Kawakami, T. Ono, and T. Taki
CD41+/CD45+ Cells Without Acetylcholinesterase Activity Are Immature and a Major Megakaryocytic Population in Murine Bone Marrow
Stem Cells, April 1, 2007; 25(4): 862 - 870.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. Yang, H. Hisha, Y. Cui, T. Fan, T. Jin, Q. Li, Z. Lian, N. Hosaka, Y. Li, and S. Ikehara
A New Assay Method for Late CFU-S Formation and Long-Term Reconstituting Activity Using a Small Number of Pluripotent Hemopoietic Stem Cells
Stem Cells, May 1, 2002; 20(3): 241 - 248.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Ikehara
Pluripotent Hemopoietic Stem Cells in Mice and Humans
Experimental Biology and Medicine, February 1, 2000; 223(2): 149 - 155.
[Abstract] [Full Text]


Home page
Stem CellsHome page
B. Feng, M. Inaba, Z. Lian, Y. Cui, J. Toki, T. Ito, T. Jin, T. Fan, G. Yang, C. Yu, et al.
Development of Mouse Dendritic Cells from Lineage-Negative c-kit‹low Pluripotent Hemopoietic Stem Cells In Vitro
Stem Cells, January 1, 2000; 18(1): 53 - 60.
[Abstract] [Full Text]


Home page
BloodHome page
S. Reid, A. Ritchie, L. Boring, J. Gosling, S. Cooper, G. Hangoc, I. F. Charo, and H. E. Broxmeyer
Enhanced Myeloid Progenitor Cell Cycling and Apoptosis in Mice Lacking the Chemokine Receptor, CCR2
Blood, March 1, 1999; 93(5): 1524 - 1533.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Z. Lian, B. Feng, K. Sugiura, M. Inaba, C. Yu, T. Jin, T. Fan, Y. Cui, R. Yasumizu, J. Toki, et al.
c-kit
Stem Cells, January 1, 1999; 17(1): 39 - 44.
[Abstract] [Full Text]


Home page
Stem CellsHome page
C.-Z. Yu, H. Hisha, Y. Li, Z. Lian, T. Nishino, J. Toki, Y. Adachi, M. Inaba, T.-X. Fan, T. Jin, et al.
Stimulatory Effects of Hepatocyte Growth Factor on Hemopoiesis of SCF/c-kit System-Deficient Mice
Stem Cells, January 1, 1998; 16(1): 66 - 77.
[Abstract] [Full Text]


Home page
Stem CellsHome page
Z. Lian, J. Toki, C. Yu, H. Hayashi, R. Yasumizu, K. Sugiura, T. Jin, M. Inaba, H. Hisha, Y. Li, et al.
Intrathymically Injected Hemopoietic Stem Cells Can Differentiate into All Lineage Cells in the Thymus: Differences Between c-kit+ Cells and c-kit
Stem Cells, November 1, 1997; 15(6): 430 - 436.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 1997 by AlphaMed Press.